31539-54-5

Basic information

• Product Name: 2-amino-3-[5-[bis(2-chloroethyl)amino]-1-phenyl-benzoimidazol-2-yl]pro panoic acid
• Synonyms: 2-amino-3-[5-[bis(2-chloroethyl)amino]-1-phenyl-benzoimidazol-2-yl]pro panoic acid;IMET 3146
• CAS NO: 31539-54-5
• Molecular Formula: C20H22Cl2N4O2
• Molecular Weight: 0
• Mol File: 31539-54-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 647.4°C at 760 mmHg
• Flash Point: 345.3°C
• Appearance: /
• Density: 1.38g/cm³
• Vapor Pressure: 1.21E-17mmHg at 25°C
• Refractive Index: 1.646
• CAS DataBase Reference: 2-amino-3-[5-[bis(2-chloroethyl)amino]-1-phenyl-benzoimidazol-2-yl]pro panoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-3-[5-[bis(2-chloroethyl)amino]-1-phenyl-benzoimidazol-2-yl]pro panoic acid(31539-54-5)
• EPA Substance Registry System: 2-amino-3-[5-[bis(2-chloroethyl)amino]-1-phenyl-benzoimidazol-2-yl]pro panoic acid(31539-54-5)

Safety Data

• Hazardous Substances Data: 31539-54-5(Hazardous Substances Data)

Usage

Potential Actions

Antineoplastic: Possesses properties that counteract the growth and spread of tumors.
Antitumor: Exhibits properties that combat the formation and development of tumors.

Chemical Classification

Synthetic alkylating agent belonging to the class of nitrogen mustard compounds.

Target

DNA

Mechanism of Action

Disrupts DNA replication and transcription processes.

Resulting Effect

Induces cell death.

Research Focus

Cancer Treatment: Investigated for its efficacy in treating cancer, particularly solid tumors and lymphomas.

Clinical Status

Undergoing clinical trials to assess safety and efficacy.

Potential Application

Promising candidate for cancer therapy.

InChI:InChI=1/C20H22Cl2N4O2/c21-8-10-25(11-9-22)15-6-7-18-17(12-15)24-19(13-16(23)20(27)28)26(18)14-4-2-1-3-5-14/h1-7,12,16H,8-11,13,23H2,(H,27,28)